First experience of topical SDZ ASM 981 in children with atopic dermatitis
Authors: J. Harper, A. Green, G. Scott, E. Gruendl, B. Dorobek, M. Cardno, P. Burtin
Journal: British Journal of Dermatology (2001)

Journal Article First experience of topical SDZ ASM 981 in children with atopic dermatitis Get access J. Harper, J. Harper Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, London WC1 3JH, U.K. *Departments of Clinical Pharmacology, Biostatistics, and Drug Metabolism & Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland †Department of Clinical Pharmacology, Novartis Research Centre, Horsham, U.K. Dr John Harper. Search for other works by this author on: Oxford Academic Google Scholar A. Green, A. Green Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, London WC1 3JH, U.K. *Departments of Clinical Pharmacology, Biostatistics, and Drug Metabolism & Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland †Department of Clinical Pharmacology, Novartis Research Centre, Horsham, U.K. Search for other works by this author on: Oxford Academic Google Scholar G. Scott, G. Scott Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, London WC1 3JH, U.K. *Departments of Clinical Pharmacology, Biostatistics, and Drug Metabolism & Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland †Department of Clinical Pharmacology, Novartis Research Centre, Horsham, U.K. Search for other works by this author on: Oxford Academic Google Scholar E. Gruendl, E. Gruendl Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, London WC1 3JH, U.K. *Departments of Clinical Pharmacology, Biostatistics, and Drug Metabolism & Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland †Department of Clinical Pharmacology, Novartis Research Centre, Horsham, U.K. Search for other works by this author on: Oxford Academic Google Scholar B. Dorobek, B. Dorobek Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, London WC1 3JH, U.K. *Departments of Clinical Pharmacology, Biostatistics, and Drug Metabolism & Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland †Department of Clinical Pharmacology, Novartis Research Centre, Horsham, U.K. Search for other works by this author on: Oxford Academic Google Scholar M. Cardno, M. Cardno Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, London WC1 3JH, U.K. *Departments of Clinical Pharmacology, Biostatistics, and Drug Metabolism & Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland †Department of Clinical Pharmacology, Novartis Research Centre, Horsham, U.K. Search for other works by this author on: Oxford Academic Google Scholar P. Burtin P. Burtin Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, London WC1 3JH, U.K. *Departments of Clinical Pharmacology, Biostatistics, and Drug Metabolism & Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland †Department of Clinical Pharmacology, Novartis Research Centre, Horsham, U.K. Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 144, Issue 4, 1 April 2001, Pages 781–787, https://doi.org/10.1046/j.1365-2133.2001.04133.x Published: 01 April 2001